Study of AZD0466 monotherapy or in combination in patients with advanced haematological malignancies

Trial Identifier: D8241C00001
Sponsor: AstraZeneca
Start Date: June 2021
Primary Completion Date: August 2023
Study Completion Date: August 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation
Spanish (United States) Translation
French Translation
Italian Translation
Korean Translation

Trial Locations

Country Location
AU Melbourne, AU, 3004
AU Parkville, AU, 3050
DE Aachen, DE, 52074
DE Heidelberg, DE, 69120
DE Kiel, DE, 24105
FR Pessac, FR, 33604
IT Bologna, IT, 40138
IT Meldola, IT, 47014
IT Rozzano, IT, 20089
KR Busan, KR, 47392
US, CA Duarte, CA, US, 91010
US, FL Jacksonville, FL, US, 32224
US, IL Chicago, IL, US, 60611
US, OH Columbus, OH, US, 43210
US, TX Houston, TX, US, 77030